Altor BioScience: Miramar cancer drug developer merges with California firm in deal exceeding $1 billion

Miramar-based Altor BioScience Corp., which is developing treatments to combat cancer and infectious diseases, has merged with a California biotech in a deal valued at more than $1 billion, Altor's founder has confirmed.Altor is now primarily owned by NantCell, founded by cancer entrepreneur Dr....